Non-Toxic Compound Eliminate Pathogens at Low Concentrations

Akwaton, a new disinfectant that works at extremely low concentrations, could be used in healthcare settings to help control persistent hospital-acquired infections such as Clostridium difficile, according to a Society for General Microbiology news release.

Advertisement

 

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

Researchers from the Université de Saint-Boniface in Winnipeg, Canada tested Akwaton against bacterial spores that attach to surfaces and are difficult to destroy. The present study showed that Akwaton was able to destroy Bacillus subtilis bacterial spores, suspended in water and attached to stainless steel or glass surfaces, at concentrations well below 1 percent after just 90 seconds of treatment. It was equally as effective at more dilute concentrations (below 0.1 percent) if left to act for longer periods.

Previous work has shown Akwaton is also effective at low concentrations against strains of Meticillin-resistant Staphylococcus aureus and Escherichia coli.

More Articles on Infection Control:

Inexact Data May Be Contributing to Antibiotic Overuse

Fifth Michigan Hospital to Test Patients for Hep C in Connection to Exeter Outbreak

GAO: More Data Needed on Injection Safety in Ambulatory Care Settings

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.